Low-dose statin treatment increases prostate cancer aggressiveness

Prostate cancer is diagnosed late in life, when co-morbidities are frequent. Among them, hypertension, hypercholesterolemia, diabetes or metabolic syndrome exhibit an elevated incidence. In turn, prostate cancer patients frequently undergo chronic pharmacological treatments that could alter disease...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Caro-Maldonado, Alfredo, Camacho, Laura, Zabala-Letona, Amaia, Torrano, Verónica, Fernández-Ruiz, Sonia, Zamacola-Bascaran, Kepa, Arreal, Leire, Valcárcel-Jiménez, Lorea, Martín-Martín, Natalia, Flores, Juana M., Cortazar, Ana R., Zúñiga-García, Patricia, Arruabarrena-Aristorena, Amaia, Guillaumond, Fabienne, Cabrera, Diana, Falcón-Perez, Juan M., Aransay, Ana M., Gomez-Muñoz, Antonio, Olivan, Mireia, Morote, Juan, Carracedo, Arkaitz
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Priority Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788577/
https://ncbi.nlm.nih.gov/pubmed/29416709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22217
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires